Sedatives/Hypnotics,Other ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 107 | Juvenile idiopathic arthritis | 1 |
107. Juvenile idiopathic arthritis
Clinical trials : 441 / Drugs : 282 - (DrugBank : 56) / Drug target genes : 52 - Drug target pathways : 142
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03069638 (ClinicalTrials.gov) | February 1, 2017 | 20/12/2016 | Intranasal Dexmedetomidine Sedation During Intra-articular Joint Injections in Pediatric Population | Intranasal Dexmedetomidine Sedation During Intra-articular Joint Injections in Pediatric Population | Juvenile Idiopathic Arthritis;Joint Inflammation | Drug: Dexmedetomidine;Drug: Sedatives/Hypnotics,Other | University of Oulu | NULL | Recruiting | 1 Year | 18 Years | All | 109 | Phase 4 | Finland |